First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial
1. 系统已在2026-08-21 15:33:23对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1038/s41591-026-04564-7
文献链接: https://www.nature.com/articles/s41591-026-04564-7
其他信息:
出版社: Springer Science and Business Media LLC
作者: Xiying Shao; Can Tian; Zhanhong Chen; Jian Huang; Yongsheng Wang; Tao Sun; Tienan Yi; Yifen Wu; Weihua Sun; Xufang Yu; Zhongmin Maxwell Wang; Baiyong Li; Yu Xia; Xiaojia Wang; Quchang Ouyang
全文下载地址: https://www.nature.com/articles/s41591-026-04564-7.pdf

